Serum Institute reduces Covishield price for states from Rs 400 to Rs 300 per dose

NEW DELHI: Serum Institute of India on Wednesday announced that it was reducing the price of its Covishield vaccine from Rs 400 to Rs 300 per dose for the states as a "philanthropic gesture".
"As a philanthropic gesture on behalf of Serum Institute of India, I hereby reduce the price to the states from Rs 400 to Rs 300 per dose, effective immediately, SII CEO Adar Poonawalla said on Twitter.
Read our coronavirus live blog for all the latest news and updates

"This will save thousands of crores of state funds going forward. This will enable more vaccinations and save countless lives," he added.

The Pune-based Serum Institute of India (SII), the world's largest vaccine maker in terms of volume, had announced a price of Rs 400 per dose for its Covid-19 vaccine, 'Covishield', for state governments and Rs 600 per dose for private hospitals.
The central government on Monday had asked the Serum Institute and Bharat Biotech to lower price of their Covid-19 vaccines amid criticism from various states who accused the companies of profiteering during such a major crisis.
Watch Covid-19: Serum Institute of India slashes 'Covishield' price to Rs 300